Ryzodeg QUIZ May 2023

Ryzodeg QUIZ May 2023

Professional Development

20 Qs

quiz-placeholder

Similar activities

PRE TEST MINI SEMINAR & SALES CLINIC FA

PRE TEST MINI SEMINAR & SALES CLINIC FA

Professional Development

20 Qs

STEM for Education

STEM for Education

Professional Development

20 Qs

BET V.1

BET V.1

Professional Development

15 Qs

CME CARDIO WEEK 4 : ACLS

CME CARDIO WEEK 4 : ACLS

Professional Development

16 Qs

English for Nursing - Hospital Departments (Pair)

English for Nursing - Hospital Departments (Pair)

University - Professional Development

20 Qs

Lean Basics

Lean Basics

Professional Development

18 Qs

Gastrointestinal / Endocrine Emergencies

Gastrointestinal / Endocrine Emergencies

KG - Professional Development

25 Qs

Therapy Refresher - Diabetes

Therapy Refresher - Diabetes

Professional Development

24 Qs

Ryzodeg QUIZ May 2023

Ryzodeg QUIZ May 2023

Assessment

Quiz

Other

Professional Development

Easy

Created by

Salman Anzar

Used 6+ times

FREE Resource

20 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

In step by step trial primary end point was Change from baseline in HbA1c after 26 weeks.

True

False

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Nocturnal confirmed hypoglycaemia with IDegAsp lower in step by step trial after 26 weeks was ____ and after 38 weeks was ____ ?

43%, 34%

45%, 39%

41%, 14%

None of these

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

In step by step trial patients included treated with regimen like.

OADs

Basal Insulin

Basal Bolus Insulin

on Premix Insulins in previous 3 months

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Initial Starting dose of Insulin Aspart in Step by Step intensification trial was

4 Units

6 Units

8 Units

According to Body weight

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Confirmed hypoglycaemia in step by step intensification trial ____ lower at week 26, ____ lower at week 38.

14%, 10%

12%, 14%

10%, 14%

15%,20%

6.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Total number of patients included in step by step intensification trial.

521 patients

532 patients

582 patients

696 patients

7.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

CONFIRM trial is comparative effectiveness of degludec (either 100 or 200 units/mL) versus glargine U300 in insulin-naïve adult patients with T2D.

True

False

Create a free account and access millions of resources

Create resources
Host any resource
Get auto-graded reports
or continue with
Microsoft
Apple
Others
By signing up, you agree to our Terms of Service & Privacy Policy
Already have an account?